Free The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets Case Study Solution | Assignment Help

Harvard Case - The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets

"The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets" Harvard business case study is written by Zhigang Tao, W.H. Lo. It deals with the challenges in the field of General Management. The case study is 43 page(s) long and it was first published on : Sep 4, 2014

At Fern Fort University, we recommend a comprehensive and multi-faceted approach to address the GSK scandal. This includes a robust change management program focusing on organizational culture, leadership, and ethics to ensure future compliance and ethical conduct. We also suggest a strategic review of GSK's global strategy, operations strategy, and supply chain management to mitigate future risks and foster sustainable growth in emerging markets.

2. Background

The GSK scandal involved allegations of bribery and corruption by GSK executives in China. This case highlights the complexities of doing business in emerging markets, where regulatory environments and ethical standards can differ significantly from those in developed countries. The main protagonists are GSK, its Chinese subsidiary, and the individuals involved in the alleged bribery scheme.

3. Analysis of the Case Study

Strategic Framework: We will analyze the case using a combination of Porter's Five Forces and SWOT analysis to understand the competitive landscape and GSK's internal strengths and weaknesses.

Porter's Five Forces:

  • Threat of New Entrants: The pharmaceutical industry has high barriers to entry due to stringent regulations, high R&D costs, and established brand loyalty.
  • Bargaining Power of Buyers: Buyers have limited bargaining power due to the lack of substitutes for many pharmaceutical products.
  • Bargaining Power of Suppliers: Suppliers have moderate bargaining power, with some specialized ingredients and raw materials being crucial.
  • Threat of Substitutes: Generic drug manufacturers pose a significant threat, especially in emerging markets where price sensitivity is high.
  • Competitive Rivalry: The industry is highly competitive, with global players vying for market share, particularly in rapidly growing emerging markets.

SWOT Analysis:

Strengths:

  • Strong brand reputation
  • Extensive research and development capabilities
  • Global distribution network
  • Experienced workforce

Weaknesses:

  • Weak internal controls and governance
  • Lack of cultural sensitivity in emerging markets
  • Inadequate training and awareness regarding ethical conduct
  • Over-reliance on sales incentives

Opportunities:

  • Growing demand for healthcare in emerging markets
  • Potential for partnerships and collaborations
  • Technological advancements in drug development and delivery

Threats:

  • Stringent regulations and ethical scrutiny in emerging markets
  • Increased competition from local and global players
  • Potential for reputational damage and financial losses

Financial Analysis:

  • The scandal resulted in significant financial penalties and reputational damage, impacting GSK's stock price and overall profitability.
  • The company's future financial performance will depend on its ability to regain trust, strengthen internal controls, and adapt its business practices to comply with international regulations.

Marketing Analysis:

  • The scandal negatively impacted GSK's brand image, particularly in China and other emerging markets.
  • The company needs to rebuild trust with consumers and stakeholders through transparent communication, ethical business practices, and community engagement initiatives.

Operational Analysis:

  • The scandal exposed weaknesses in GSK's operations and supply chain management in China.
  • The company needs to implement stricter internal controls, improve risk management processes, and enhance its understanding of local regulations and cultural nuances.

4. Recommendations

1. Organizational Culture and Ethics Transformation:

  • Implement a comprehensive ethics and compliance program: This program should include mandatory training for all employees, clear ethical guidelines, and whistleblowing mechanisms.
  • Establish a strong corporate governance framework: This framework should include independent oversight, clear accountability, and robust internal controls.
  • Promote a culture of integrity and transparency: This can be achieved through leadership by example, ethical decision-making processes, and open communication.
  • Focus on diversity and inclusion: A diverse workforce brings different perspectives and helps mitigate cultural biases.

2. Strategic Review and Global Expansion:

  • Conduct a thorough review of GSK's global strategy: This review should assess the company's market presence, competitive position, and growth potential in emerging markets.
  • Develop a tailored strategy for each emerging market: This strategy should consider local regulations, cultural sensitivities, and consumer preferences.
  • Invest in local talent and partnerships: This will help GSK build trust and navigate local complexities more effectively.
  • Prioritize ethical sourcing and manufacturing practices: This will ensure compliance with international standards and minimize risks.

3. Operations and Supply Chain Management:

  • Strengthen internal controls and risk management: This includes implementing robust systems for tracking expenses, monitoring sales activities, and detecting potential fraud.
  • Improve supply chain transparency and traceability: This will help GSK ensure that its products are sourced and manufactured ethically.
  • Invest in technology and analytics: This will enable GSK to better monitor its operations, identify potential risks, and make data-driven decisions.
  • Develop a robust crisis management plan: This plan should outline procedures for responding to allegations of misconduct, communicating with stakeholders, and mitigating reputational damage.

5. Basis of Recommendations

These recommendations are based on the following:

  • Core competencies and consistency with mission: GSK's core competencies in research and development, global reach, and brand reputation are essential for long-term success. The recommendations aim to leverage these strengths while addressing the weaknesses exposed by the scandal.
  • External customers and internal clients: The recommendations focus on rebuilding trust with customers, stakeholders, and employees. This will involve transparent communication, ethical business practices, and a commitment to integrity.
  • Competitors: The recommendations aim to strengthen GSK's competitive position by addressing vulnerabilities and improving its operational efficiency.
  • Attractiveness ' quantitative measures: The recommendations are expected to improve GSK's financial performance by mitigating risks, enhancing operational efficiency, and fostering sustainable growth.
  • Assumptions: The recommendations assume that GSK is committed to ethical conduct and is willing to invest in the necessary resources to implement the changes.

6. Conclusion

The GSK scandal serves as a stark reminder of the importance of ethical conduct and responsible business practices in a globalized world. By implementing the recommendations outlined above, GSK can rebuild trust, strengthen its brand image, and achieve sustainable growth in emerging markets.

7. Discussion

Alternatives:

  • Ignoring the scandal: This would likely lead to further reputational damage and legal consequences.
  • Limited response: A limited response, such as simply issuing a public apology, would not be sufficient to address the underlying issues.

Risks:

  • Resistance to change: Employees may resist changes to the organizational culture and processes.
  • Implementation challenges: Implementing the recommendations will require significant resources and commitment from GSK's leadership team.
  • Unforeseen circumstances: The global business environment is constantly evolving, and GSK may face unforeseen challenges in emerging markets.

Key Assumptions:

  • GSK is committed to ethical conduct and is willing to invest in the necessary resources to implement the changes.
  • The recommendations will be implemented effectively and efficiently.
  • The global business environment will remain relatively stable.

8. Next Steps

  • Develop a detailed implementation plan: This plan should outline specific actions, timelines, and responsible parties for each recommendation.
  • Secure buy-in from senior management: This is crucial for the success of the change management program.
  • Communicate the changes to employees and stakeholders: This will help build understanding and support for the new approach.
  • Monitor progress and make adjustments as needed: The implementation process should be iterative, with ongoing monitoring and evaluation to ensure effectiveness.

By taking these steps, GSK can emerge from the scandal stronger, more ethical, and better positioned for long-term success in the global marketplace.

Hire an expert to write custom solution for HBR General Management case study - The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets

more similar case solutions ...

Case Description

China's healthcare reforms in the 1980s left the country's hospitals under-subsidized and its medical officials underpaid. Hospitals relied on profits generated from the provision of medical services to cover the funding gap, while doctors became kickback seekers to make up for their low rates. In traditional markets, global pharmaceutical companies ("pharm companies") are no strangers to wooing hospitals and doctors to favor prescriptions of their drugs. These questionable "marketing" practices were taken to the next level in the China market. Streams of financial flows, legal or not, from pharm companies to hospitals and doctors to win their favor in prescribing their drugs became a structurally embedded problem of the country's healthcare system. The Chinese government introduced a new round of reform in 2009. While it promises to spend millions more on healthcare, its action to wipe out bribery and other kickback-seeking behaviors of the industry left many players perplexed. The first to take the heat was GlaxoSmithKline Inc. ("GSK"), a large British pharm company active in the China market since 1984. In July 2013, the Chinese government launched an investigation on GSK's China operation regarding its activities that lure hospitals doctors and administers to buy GSK drugs. The alleged practice of bribery is an industry open secret common to pharm companies. Is this investigation an indication that the Chinese government is targeting multinationals in favor of local players? Despite high-voltage growth rates, this regulated industry in the market economy with Chinese characteristics only has a bare-boned distributions infrastructure, while it is filled with patient-trying administrative hurdles, has price restrictions on an expanded list of drugs, and offers weak institutional protection for companies' intellectual property. Will long-term investment in the country pay off? Should GSK continue its China business? Should it change its strategy in China?

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets

Hire an expert to write custom solution for HBR General Management case study - The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets

The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets FAQ

What are the qualifications of the writers handling the "The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets. Where can I get it?

You can find the case study solution of the HBR case study "The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets" at Fern Fort University.

Can I Buy Case Study Solution for The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR General Management case study - The GSK Scandal: When Questionable Global Practices Met Imperfect Institutions in Emerging Markets




Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.